Showing results (651-660 of 697) with videos related to

Sort By:
Pageof 70
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|October 6, 2025
Insights Into Veterans' Motivations and Hesitancies for COVID-19 Vaccine Uptake: A Mixed-Methods AnalysisAlexis K Barrett, Jaime E Sidani, Kelly H Burkitt, et al.
Hypertension (Dallas, Tex. : 1979)|February 21, 2008
Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodelingAndreas M Beyer, Gary L Baumbach, Carmen M Halabi, et al.
Frontiers in Oncology|August 25, 2023
Redlining-associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenomeJasmine M Miller-Kleinhenz, Leah Moubadder, Kirsten M Beyer, et al.
Oncogene|October 11, 2016
HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancerN Stojanovic, Z Hassan, M Wirth, et al.
Circulation Research|December 25, 2015
Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human MicrocirculationAndreas M Beyer, Julie K Freed, Matthew J Durand, et al.
JCI Insight|September 30, 2025
Characterization of anticancer therapy-induced microvascular dysfunction in patients with breast cancer supports targeted interventionJanée D Terwoord, Laura E Norwood Toro, Shelby N Hader, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonistsJohn E Tellew, Rose Ann F Baska, Sophie M Beyer, et al.
Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Blood Advances|April 10, 2024
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancerSteven E Schild, James A Bonner, Thomas G Shanahan, et al.
Pageof 70